Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

ProVen Growth and Income VCT plc: Transaction in Own Shares

31 Aug 2023 17:00

ProVen Growth and Income VCT plc: Transaction in Own Shares

ProVen Growth and Income VCT plc Transaction in own shares31 August 2023

ProVen Growth and Income VCT plc announces that, on 31 August 2023, it purchased the following shares for cancellation:

 No. purchasedPrice paid per share% of class in issue
Ordinary shares of 1.6187p each1,028,43948.68p 0.33%

Beringea LLPCompany SecretaryTelephone: 020 7845 7820

-End

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.